Antiplasmodial activity of extracts of 25 cyanobacterial species from coastal regions of Tamil Nadu

References

• Altschul SF, Gish W, Miller W, et al. (1990). Basic local alignment search tool. J Mol Biol 215:403–10
   Google Scholar
• Balunas MJ, Linington RG, Tidgewell K, et al. (2010). Dragonamide E, a modified linear lipopeptide from Lyngbya majuscula with antileishmanial activity. J Nat Prod 73:60–6
   PubMed Web of Science ®Google Scholar
• Burrows JN, Chibale K, Wells TN. (2011). The state of the art in antimalarial drug discovery and development. Curr Top Med Chem 11:1226–54
   PubMed Web of Science ®Google Scholar
• Chang TT, More SV, Lu I, et al. (2011). Isomalyngamide A, A-1 and their analogs suppress cancer cell migration in vitro. Eur J Med Chem 46:3810–19
   PubMed Web of Science ®Google Scholar
• Clark BR, Engene N, Teasdale ME, et al. (2008). Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum. J Nat Prod 71:1530–7
   PubMed Web of Science ®Google Scholar
• Costa M, Costa-Rodrigues J, Fernandes MH, et al. (2012). Marine cyanobacteria compounds with anticancer properties: A review on the implication of apoptosis. Mar Drugs 10:2181–207
   PubMed Web of Science ®Google Scholar
• Desikachari TV. (1959). Cyanophyta. ICAR Monographs on Algae. New Delhi: Indian Council of Agricultural Research
   Google Scholar
• Doyle JJ, Doyle JL. (1987). A rapid DNA isolation procedure for small quantities of fresh leaf tissue. Phytochem Bull 19:11–5
   Google Scholar
• Dondorp AM, Nosten F, Yi P, et al. (2000). Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361:455–67
   Google Scholar
• Edwards DJ, Marquez BL, Nogle LM, et al. (2004). Structure and biosynthesis of the jamaicamides, new mixed polyketide peptide neurotoxins from the marine cyanobacterium Lyngbya majuscula. Chem Biol 11:817–33
   PubMed Web of Science ®Google Scholar
• Fattorusso E, Taglialatela-Scafati O. (2009). Marine antimalarials. Mar Drugs 7:130–52
   PubMed Web of Science ®Google Scholar
• Froscio SM, Humpage AR, Burcham PC, Falconer IR. (2003). Cylindrospermopsin induced protein synthesis inhibition and its dissociation from acute toxicity in mouse hepatocytes. Environ Toxicol 18:243–51
   PubMed Web of Science ®Google Scholar
• Gunasekera SP, Owle CS, Montaser R, et al. (2011). Malyngamide 3 and cocosamides A and B from the marine cyanobacterium Lyngbya majuscula from Cocos Lagoon, Guam. J Nat Prod 74:871–6
   PubMed Web of Science ®Google Scholar
• Gutiérrez M, Tidgewell K, Capson TL, et al. (2010). Malyngolide dimer, a bioactive symmetric cyclodepside from the panamanian marine cyanobacterium, Lyngbya majuscula. J Nat Prod 73:709–11
   PubMed Web of Science ®Google Scholar
• Inbaneson SJ, Ravikumar S. (2011). In vitro antiplasmodial activity of marine sponge Hyattella intestinalis associated bacteria against Plasmodium falciparum. Asian Pac J Trop Biomed 1:S100–4
   Google Scholar
• Iwasaki A, Teruya T, Suenaga K. (2010). Isolation and structure of koshikalide, a 14-membered macrolide from the marine cyanobacterium Lyngbya sp. Tetrahedron Lett 51:959–60
   Web of Science ®Google Scholar
• Lambros C, Vanderberg JP. (1979). Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65:418–20
   PubMed Web of Science ®Google Scholar
• Linington RG, González J, Urena L, et al. (2007). Venturamides A and B: Antimalarial constituents of the panamanian marine cyanobacterium Oscillatoria sp. J Nat Prod 70:397–401
   PubMed Web of Science ®Google Scholar
• Linington RG, Clark BR, Trimble EE, et al. (2009). Antimalarial peptides from marine cyanobacteria: Isolation and structural elucidation of gallinamide A. J Nat Prod 72:14–7
   PubMed Web of Science ®Google Scholar
• Ma C, Harrison P, Wang L, Coppel RL. (2010). Automated estimation of parasitaemia of Plasmodium yoelii infected mice by digital image analysis of Giemsa-stained thin blood smears. Malar J 9:1–9
   PubMed Web of Science ®Google Scholar
• Malloy KL, Villa FA, Engene N, et al. (2011). Malyngamide2, an oxidized lipopeptide with nitric oxide inhibiting activity from a Papua New Guinea marine cyanobacterium. J Nat Prod 74:95–8
   PubMed Web of Science ®Google Scholar
• Maruthanayagam V, Nagarajan M, Sundararaman M. (2013). Cytotoxicity assessment of cultivable marine cyanobacterial extracts in Artemia salina (brine shrimp) larvae and cancer cell lines. Toxin Rev 32:1–9
   Google Scholar
• McPhail KL, Correa J, Linington RG, et al. (2007). Antimalarial linear lipopeptides from a panamanian strain of the marine cyanobacterium, Lyngbya majuscula. J Nat Prod 70:984–8
   PubMed Web of Science ®Google Scholar
• Montaser R, Abboud K, Paul VJ, Luesch H. (2011). Pitiprolamide, a proline-rich dolastatin16 analogue from the marine cyanobacterium Lyngbya majuscula from Guam. J Nat Prod 74:109–12
   PubMed Web of Science ®Google Scholar
• Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
   PubMed Web of Science ®Google Scholar
• Nagarajan M, Maruthanayagam V, Sundararaman M. (2012). A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites. J Appl Toxicol 32:153–85
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. (2007). Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461–7
   PubMed Web of Science ®Google Scholar
• Noedl H, Se Y, Socheat D, Fukuda MM. (2008). Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med 359:2619–20
   PubMed Web of Science ®Google Scholar
• Nübel U, Garcia-Pichel F, Muyzer G. (1997). PCR primers to amplify 16S rRNA genes from cyanobacteria. Appl Environ Microbiol 63:3327–32
   PubMed Web of Science ®Google Scholar
• Nunnery JK, Mevers E, Gerwick WH. (2010). Biologically active secondary metabolites from marine cyanobacteria. Curr Opin Biotechnol 21:787–93
   PubMed Web of Science ®Google Scholar
• Papendorf O, Koenic GM, Wright AD. (1998). Hierridin b and 2,4-dimethoxy-6-heptadecyl-phenol, secondary metabolites from the cyanobacterium Phormidium ectocarpi with antimalarial activity. Phytochemistry 49:2383–6
   PubMed Web of Science ®Google Scholar
• Ravikumar S, Inbaneson SJ, Suganthi P, et al. (2011a). Mangrove plants as a source of lead compounds for the development of new antiplasmodial drugs from South East coast of India. Parasitol Res 108:1405–10
   PubMed Web of Science ®Google Scholar
• Ravikumar S, Inbaneson SJ, Suganthi P, et al. (2011b). In vitro antiplasmodial activity of ethanolic extracts of seaweed macroalgae against Plasmodium falciparum. Parasitol Res 108:1411–6
   PubMed Web of Science ®Google Scholar
• Rickards RW, Rothschild JM, Willis AC, et al. (1999). Calothrixins A and B, novel pentacyclic metabolites from Calothrix cyanobacteria with potent activity against malaria parasites and human cancer cells. Tetrahedron 55:13513–20
   Web of Science ®Google Scholar
• Rippka R, Deruelles J, Waterbury JB, et al. (1979). Generic assignments, strain histories and properties of pure cultures of cyanobacteria. J Gen Microbiol 111:1–61
   Google Scholar
• Simmons TL, Engene N, Urena LD, et al. (2008). Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium, Oscillatoria nigro-viridis. J Nat Prod 71:1544–50
   PubMed Web of Science ®Google Scholar
• Sharma N, Mohanakrishnan D, Shard A, et al. (2012). Stilbene-chalcone hybrids: Design, synthesis, and evaluation as a new class of antimalarial scaffolds that trigger cell death through stage specific apoptosis. J Med Chem 12:297–311
   Google Scholar
• Smilkstein M, Sriwilaijaro N, Kelly JX, et al. (2004). Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48:1803–6
   PubMed Web of Science ®Google Scholar
• Stolze SC, Deu E, Kaschani F, et al. (2012). The antimalarial natural product symplostatin 4 is a nanomolar inhibitor of the food vacuole falcipains. Chem Biol 19:1546–55
   PubMedGoogle Scholar
• Tamura K, Dudley J, Nei M, Kumar S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596–9
   PubMed Web of Science ®Google Scholar
• Tan LT. (2007). Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry 68:954–79
   PubMed Web of Science ®Google Scholar
• Thornburg CC, Thimmaiah M, Shaala LA, et al. (2011). Cyclic depsipeptides, grassypeptolides D and E and ibuepidemethoxylyngbyastatin 3, from a Red Sea Leptolyngbya cyanobacterium. J Nat Prod 74:1677–85
   PubMed Web of Science ®Google Scholar
• Trager W, Jensen JB. (1976). Human malaria parasites in continuous culture. Science 193:673–5
   PubMed Web of Science ®Google Scholar
• Tripathi A, Puddick J, Prinsep MR, et al. (2010a). Lagunamides A and B: Cytotoxic and antimalarial cyclodepsipeptides from the marine cyanobacterium, Lyngbya majuscula. J Nat Prod 73:1810–4
   PubMed Web of Science ®Google Scholar
• Tripathi A, Puddick J, Prinsep MR, et al. (2010b). Hantupeptins B and C, cytotoxic cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula. Phytochemistry 71:307–11
   PubMed Web of Science ®Google Scholar
• Tripathi A, Puddick J, Prinsep MR, et al. (2011). Lagunamide C, a cytotoxic cyclodepsipeptide from the marine cyanobacterium, Lyngbya majuscula. Phytochemistry 72:2369–75
   PubMed Web of Science ®Google Scholar
• Vincent WF. (2009). Cyanobacteria. In: Likens GE, ed. Encyclopedia of Inland Water. Vol. 3. Oxford: Elsevier, 226–32
   Google Scholar
• White NJ. (2010). Artemisinin resistance: The clock is ticking. Lancet 376:2051–2
   PubMed Web of Science ®Google Scholar
• World Malaria Report (2011) World Health Organization. Available from: http://www.who.int/malaria/publications/atoz/9789241564403/en/index.html [last accessed 6 Dec 2013]
   Google Scholar
• Yadav S, Sinha RP, Tyagi MB, Kumar A. (2011). Cyanobacterial secondary metabolites. Int J Pharm Bio Sci 2:144–67
   Google Scholar